Tobacco Cessation

0
Pipeline Programs
1
Companies
9
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
spirometryN/A5 trials
Active Trials
NCT06172777Completed801Est. Aug 2024
NCT05219773Unknown68Est. May 2022
NCT04293445Unknown100Est. Jul 2022
+2 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AstraZenecaspirometry
AstraZenecaspirometry
AstraZenecaspirometry
AstraZenecaspirometry
AstraZenecaspirometry
AstraZenecaspirometry
AstraZenecaspirometry
AstraZenecaspirometry
AstraZenecaspirometry

Clinical Trials (9)

Total enrollment: 9,491 patients across 9 trials

Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD

Start: Apr 2006Est. completion: Jun 20070
Phase 4Withdrawn

A Study to Evaluate the Consistency of Oscillometry and Spirometry Test Results in Patients With Confirmed or Suspected Asthma or COPD

Start: Feb 2024Est. completion: Aug 2024801 patients
N/ACompleted

Clinic Versus Home Spirometry

Start: Dec 2021Est. completion: May 202268 patients
N/AUnknown

Asthma: Phenotyping EXacerbations

Start: Nov 2019Est. completion: Jul 2022200 patients
N/AUnknown

Asthma: Phenotyping Exacerbations 2

Start: Nov 2019Est. completion: Jul 2022100 patients
N/AUnknown

Paediatric and Adult African Spirometry II

Start: Jul 2017Est. completion: Dec 20184,000 patients
N/AUnknown

Non-interventional Study of Spirometry Use to Diagnose COPD (Chronic Obstructive Pulmonary Disease) and to Prescribe Treatment to COPD Patients in the Outpatient Institutions

Start: Nov 2014Est. completion: May 20154,232 patients
N/ACompleted

Effectiveness of the Spirometry Test as a Motivational Tool for Quitting Tobacco in Primary Care

Start: May 2011Est. completion: Dec 201190 patients
N/ACompleted

Markers for Chronic Obstructive Pulmonary Disease (COPD)

Start: Jul 2001Est. completion: Jul 20020
N/AWithdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space